IperionX (ASX:IPX) said it held $77.1 million in cash as of Dec. 31, 2024, and $4.1 million was available under the Title III Defense Production Act funding in the December 2024 quarter, according to a Tuesday filing with the Australian bourse.
It said it is advancing applications for U.S. government funding, and that there is potential for accelerated review under the new administration, the filing said.
The commissioning of its titanium manufacturing campus in Virginia is progressing, and it has identified
multiple process improvements, which are expected to increase production capacity beyond nameplate levels later in the year, the filing said.
It completed the first commercial Hydrogen Assisted Metallothermic Reduction production cycle in the quarter, producing high-quality, low-oxygen titanium metal powder.
Its shares fell 3% in recent trading on Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.